SP5.1.12 Discrete Event Micro Simulation Modeling for the Treatment of Resectable Malignancy of the Oesophagus and Gastrooesophageal Junction
Abstract Aims To assist decision-making by creation of a statistical model that simulates treatment pathways and subsequent outcomes for the management of resectable malignancy of the oesophagus and gastrooesophageal junction. Methods: Discrete Event Simulation (DES) modelling is a statistical modelling technique that models the operation of a system as a sequence of events in time to support decision-making. This approach lends itself well to disease modelling by incorporating different treatment strategies targeted at different groups. It offers an advantage over previous decision analysis studies that have relied on Markov modelling which can have reduced accuracy due to lack of memory within the Markov model, the effect of depletion of susceptibles, and the timing of transitioning within the model. This simulation model was populated with data from best available evidence from contemporary randomised controlled trials and ran over 100,000 iterations. Results Neoadjuvant chemoradiotherapy was the superior treatment pathway with superior pathway selection frequency of 87.16%. For squamous cell carcinoma neoadjuvant chemoradiotherapy was the superior treatment option with 73.30 months survival time (65.60 QALMs) and had a superior pathway selection frequency of 100%. Conclusions DES simulation modeling for decision analysis in treatment of resectable malignancy of the oesophagus and gastrooesophageal junction supports the use of neoadjuvant chemoradiotherapy.